Sudden cardiac failure in a β-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia

Claudio Romani Hematology Department and Transplant Centre, ‘Armando Businco’ Cancer CentreCorrespondence[email protected]

Roberta Murru Hematology Department and Transplant Centre, ‘Armando Businco’ Cancer Centre

Martina Pettinau Hematology Department and Transplant Centre, ‘Armando Businco’ Cancer Centre

Raffaella Origa Pediatric Department, Thalassemia Unit ‘Ospedale Microcitemico’ Cagliari, Cagliari, Italy

Simona Deplano Hematology Department and Transplant Centre, ‘Armando Businco’ Cancer Centre

Emanuele Angelucci Hematology Department and Transplant Centre, ‘Armando Businco’ Cancer Centre

References

Borgna-Pignatti C, Cappellini M D, De Stefano P, Delk Vecchio GC, Forni G L, Gamberinni M R, et al. Survival and complication in talassemia. Ann NY Acad Sci 2005; 1054: 40–47
PubMed Web of Science ®Google Scholar
Sanz M A, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000; 96: 1247–1253
PubMed Web of Science ®Google Scholar
Anderson L J, Holden S, Davis B, Prescott E, Charrier C C, Bunce N H, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171–2179
PubMed Web of Science ®Google Scholar
Kottaridis P D, Peggs K, Lawrence A, Verfuerth S, Chatterjee R, Telfer P, et al. Case report: one antigen mismatched related donor bone marrow transplant in a patient with acute lymphoblastic leukaemia and β-thalassemia major: potential cure of both marrow disorders. Bone Marrow Transplant 2000; 25: 677–678
PubMed Web of Science ®Google Scholar
Sanz M A, Tallman M S, Lo Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukaemia. Blood 2005; 105: 3019–3025
PubMed Web of Science ®Google Scholar
Cvetkovic R S, Scott L J. Dexrazoxane: a review of its use for cardioprotection during anthracycline chemotherapy. Drugs 2005; 65: 1005–1024
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Sudden cardiac failure in a β-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Sudden cardiac failure in a β-thalassemia major patient receiving chemotherapy for acute promyelocytic leukemia

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date